Cigna Group
XMUN:CGN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
213.2
314.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CGN stock under the Base Case scenario is 523.73 EUR. Compared to the current market price of 232.2 EUR, Cigna Group is Undervalued by 56%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Cigna Group.
| US |
|
CVS Health Corp
NYSE:CVS
|
|
| US |
|
Cigna Corp
NYSE:CI
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Intensifying federal and state scrutiny of the pharmacy benefit management industry, especially around drug pricing transparency and rebate structures, could significantly compress Cigna’s Evernorth margins, undermining one of its core growth drivers.
Growing competition from insurtech disruptors and rival managed-care providers places pressure on Cigna’s commercial membership, potentially leading to slower enrollment growth or higher costs to retain existing clients.
Complexities from large-scale integrations, such as the Express Scripts acquisition, may sap resources and weigh on profitability if anticipated synergies fail to materialize or if operational and cultural alignments lag expectations.
Evernorth’s diversified services, ranging from pharmacy benefit management to specialty pharmacy solutions, position Cigna to capture a larger share of healthcare spending and enhance cross-selling opportunities in both commercial and government segments.
Cigna’s proven ability to manage medical cost trends, combined with strategic investments in analytics and value-based care programs, supports stable margins and differentiates the company in a competitive market.
The company’s international footprint, particularly in high-growth markets for supplemental health and expatriate benefits, provides additional avenues for revenue expansion and mitigates domestic market volatility.
Revenue & Expenses Breakdown
Cigna Group
Balance Sheet Decomposition
Cigna Group
| Current Assets | 46.7B |
| Cash & Short-Term Investments | 6.9B |
| Receivables | 31.7B |
| Other Current Assets | 8.1B |
| Non-Current Assets | 111.2B |
| Long-Term Investments | 18.5B |
| PP&E | 3.7B |
| Intangibles | 73.9B |
| Other Non-Current Assets | 15.2B |
| Current Liabilities | 56.5B |
| Accounts Payable | 9.3B |
| Accrued Liabilities | 7.7B |
| Other Current Liabilities | 39.4B |
| Non-Current Liabilities | 59.7B |
| Long-Term Debt | 30.9B |
| Other Non-Current Liabilities | 28.7B |
Free Cash Flow Analysis
Cigna Group
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Cigna Group
|
Revenue
|
268.1B
USD
|
|
Cost of Revenue
|
-242.5B
USD
|
|
Gross Profit
|
25.6B
USD
|
|
Operating Expenses
|
-15.6B
USD
|
|
Operating Income
|
10B
USD
|
|
Other Expenses
|
-3.8B
USD
|
|
Net Income
|
6.1B
USD
|
CGN Profitability Score
Profitability Due Diligence
Cigna Group's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Cigna Group's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
CGN Solvency Score
Solvency Due Diligence
Cigna Group's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Cigna Group's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CGN Price Targets Summary
Cigna Group
Dividends
Current shareholder yield for CGN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one CGN stock under the Base Case scenario is 523.73 EUR.
Compared to the current market price of 232.2 EUR, Cigna Group is Undervalued by 56%.